Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Isoform 10 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (10) (Homo sapiens (Human)) | BDBM135819 (US10085990, Example 103 | US10568888, Example 103 ...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 55 | n/a | n/a | n/a | n/a | n/a | 30 |
vTv Therapeutics LLC US Patent | Assay Description The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffe... | US Patent US9393245 (2016) BindingDB Entry DOI: 10.7270/Q2JH3K2T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Isoform 10 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (10) (Homo sapiens (Human)) | BDBM135822 (US10085990, Example 121 | US10568888, Example 121 ...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 59 | n/a | n/a | n/a | n/a | n/a | 30 |
vTv Therapeutics LLC US Patent | Assay Description The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffe... | US Patent US9393245 (2016) BindingDB Entry DOI: 10.7270/Q2JH3K2T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Isoform 10 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (10) (Homo sapiens (Human)) | BDBM135824 (US10085990, Example 127 | US10568888, Example 127 ...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 73 | n/a | n/a | n/a | n/a | n/a | 30 |
vTv Therapeutics LLC US Patent | Assay Description The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffe... | US Patent US9393245 (2016) BindingDB Entry DOI: 10.7270/Q2JH3K2T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Isoform 10 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (10) (Homo sapiens (Human)) | BDBM135823 (US10085990, Example 122 | US10568888, Example 122 ...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 80 | n/a | n/a | n/a | n/a | n/a | 30 |
vTv Therapeutics LLC US Patent | Assay Description The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffe... | US Patent US9393245 (2016) BindingDB Entry DOI: 10.7270/Q2JH3K2T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Isoform 10 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (10) (Homo sapiens (Human)) | BDBM135818 (US10085990, Example 92 | US10568888, Example 92 | ...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 151 | n/a | n/a | n/a | n/a | n/a | 30 |
vTv Therapeutics LLC US Patent | Assay Description The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffe... | US Patent US9393245 (2016) BindingDB Entry DOI: 10.7270/Q2JH3K2T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Isoform 10 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (10) (Homo sapiens (Human)) | BDBM135820 (US10085990, Example 115 | US10568888, Example 115 ...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 163 | n/a | n/a | n/a | n/a | n/a | 30 |
vTv Therapeutics LLC US Patent | Assay Description The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffe... | US Patent US9393245 (2016) BindingDB Entry DOI: 10.7270/Q2JH3K2T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Isoform 10 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (10) (Homo sapiens (Human)) | BDBM135821 (US10085990, Example 118 | US10568888, Example 118 ...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 206 | n/a | n/a | n/a | n/a | n/a | 30 |
vTv Therapeutics LLC US Patent | Assay Description The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffe... | US Patent US9393245 (2016) BindingDB Entry DOI: 10.7270/Q2JH3K2T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Isoform 10 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (10) (Homo sapiens (Human)) | BDBM135816 (US10085990, Example 54 | US10568888, Example 54 | ...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 338 | n/a | n/a | n/a | n/a | n/a | 30 |
vTv Therapeutics LLC US Patent | Assay Description The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffe... | US Patent US9393245 (2016) BindingDB Entry DOI: 10.7270/Q2JH3K2T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Isoform 10 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (10) (Homo sapiens (Human)) | BDBM135815 (US10085990, Example 51 | US10568888, Example 51 | ...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 616 | n/a | n/a | n/a | n/a | n/a | 30 |
vTv Therapeutics LLC US Patent | Assay Description The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffe... | US Patent US9393245 (2016) BindingDB Entry DOI: 10.7270/Q2JH3K2T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Isoform 10 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (10) (Homo sapiens (Human)) | BDBM135817 (US10085990, Example 84 | US10568888, Example 84 | ...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 827 | n/a | n/a | n/a | n/a | n/a | 30 |
vTv Therapeutics LLC US Patent | Assay Description The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffe... | US Patent US9393245 (2016) BindingDB Entry DOI: 10.7270/Q2JH3K2T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Isoform 10 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (10) (Homo sapiens (Human)) | BDBM135813 (US10085990, Example 32 | US10568888, Example 32 | ...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 2.50E+4 | n/a | n/a | n/a | n/a | n/a | 30 |
vTv Therapeutics LLC US Patent | Assay Description The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffe... | US Patent US9393245 (2016) BindingDB Entry DOI: 10.7270/Q2JH3K2T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Isoform 10 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (10) (Homo sapiens (Human)) | BDBM135812 (US10085990, Example 30 | US10568888, Example 30 | ...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.50E+4 | n/a | n/a | n/a | n/a | n/a | 30 |
vTv Therapeutics LLC US Patent | Assay Description The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffe... | US Patent US9393245 (2016) BindingDB Entry DOI: 10.7270/Q2JH3K2T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Isoform 10 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (10) (Homo sapiens (Human)) | BDBM135814 (US10085990, Example 33 | US10568888, Example 33 | ...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 2.50E+4 | n/a | n/a | n/a | n/a | n/a | 30 |
vTv Therapeutics LLC US Patent | Assay Description The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffe... | US Patent US9393245 (2016) BindingDB Entry DOI: 10.7270/Q2JH3K2T | |||||||||||
More data for this Ligand-Target Pair |